Fut, nem toborozFázis nélkül
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
A legfontosabb adatok
- Ki végzi
- Pentax Medical
- Hol
- Baltimore, Chapel Hill, Chicago, Cleveland, Danville, Manhasset, New York, Orange, Philadelphia, Rochester és Sarasota (Egyesült Államok)Mind a 11 helyszín megnézése
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 150 fő, tervezett
- Kezdés
- 2016. márc.
- Befejezés
- 2025. dec.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- CryoBalloon Ablation System
- A regiszteradat frissítve
- 2025. január 13.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 22 feltétel megnézéseKevesebb
Ki vehet részt
- Low- or high-grade non-nodular, previously untreated ("treatment naïve") dysplastic BE, confirmed by histopathological analysis. If nodular BE or Intramuscosal Cancer (ImCA) is identified during patient screening, this may be treated with Endoscopic Mucosal Resection (EMR) ≥6 weeks prior to treatment under this protocol. If previous EMR was performed, follow-up endoscopy must be negative for nodular BE. Patients with ImCA must be at low risk for recurrence, confirmed by EMR pathology results negative for positive margin, poorly differentiated carcinoma, and lymphovascular invasion
- BE length ≤6cm excluding visible BE islands, and Prague Classification C ≥0 / M ≥1
- Older than 18 years of age at time of consent
- Operable per institution's standards
- Provides written informed consent on the approved informed consent form
- Willing and able to comply with study requirements for follow-up
Ki nem vehet részt
- Esophageal stenosis/stricture preventing advancement of a therapeutic endoscope (patients may have the stenosis/stricture dilated and then be treated with CryoBalloon ablation under this protocol at a subsequent procedure ≥2 weeks later)
- Any endoscopically-visualized abnormalities such as ulcers, masses or nodules. Neoplastic nodules must first be treated with EMR ≥6 weeks prior to planned treatment under this protocol
- Prior distal esophagectomy
- History of esophageal cancer more extensive than T1a or not meeting criteria for low risk of recurrence (confirmed by EMR pathology results negative for positive margin, poorly differentiated carcinoma, and lymphovascular invasion)
- History of esophageal varices
- Any clinical or histological suspicion of esophageal adenocarcinoma invading into the submucosa by endoscopic mucosal resection (EMR), or confirmed T1a cancer with positive deep margin by EMR
- Life expectancy ≤3 years, as judged by the site investigator
- Non-dysplastic or indefinite for dysplasia BE, confirmed by histopathological analysis
- Symptomatic untreated strictures
- Large (>4cm) hiatal hernia
- Active esophagitis grade B or higher
- Severe medical comorbidities precluding endoscopy
- Uncontrolled coagulopathy
- Pregnant or planning to become pregnant during period of study participation
- Patient refuses or is unable to provide written informed consent
- General poor health, multiple co-morbidities placing the patient at risk or otherwise unsuitable for trial participation
Helyszínek itt: Egyesült Államok
- John HopkinsBaltimore, Egyesült Államok
- University of North Carolina School of MedicineChapel Hill, Egyesült Államok
- University of ChicagoChicago, Egyesült Államok
- University Hospitals Cleveland Medical Center*Cleveland, Egyesült Államok
- Geisinger Medical CenterDanville, Egyesült Államok
- Northwell HealthManhasset, Egyesült Államok
- New York Presbyterian Hospital-Columbia University Medical CenterNew York, Egyesült Államok
- UC IrvineOrange, Egyesült Államok
- Thomas Jefferson UniversityPhiladelphia, Egyesült Államok
- Mayo ClinicRochester, Egyesült Államok
- Sarasota Memorial HospitalSarasota, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
To evaluate the efficacy and safety of the CryoBalloon Focal Ablation System for the treatment of previously-untreated ("treatment naïve") Barrett's Esophagus (BE)
A vizsgálat csoportja
- CryoBalloon Ablation SystemEgyéb csoport
Cryoablation treatment of patients with previously untreated (treatment naïve) Barrett's epithelium.
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System for the Treatment of Patients With Previously Untreated Dysplastic Barrett's Epithelium
- Publikációk
- Durability of cryoballoon ablation for eradication of neoplastic Barrett's esophagus: a multicenter prospective cohort study (with video).Gastrointestinal endoscopy, 2026
- Multifocal Cryoballoon Ablation for Eradication of Barrett's Esophagus-Related Neoplasia: A Prospective Multicenter Clinical Trial.The American journal of gastroenterology, 2020
- A regiszteradat frissítve
- 2025. január 13.